Overview Fundamentals API Earnings EOD API Sample Code Pricing

Abcellera Biologics Inc (ABCL NASDAQ) stock market data APIs

$3.04 0.07(2.4%) as of July 19, 2024
Price chart is built with Anychart

AbCellera Biologics Inc. builds an engine for antibody drug discovery and development. Its engine discovers antibodies from natural immune responses, which are pre-enriched for antibodies. The company's preclinical products are ABCL635 for metabolic and endocrine conditions; and ABCL575 for atopic dermatitis. It has a research collaboration and license agreement with Eli Lilly and Company; a research collaboration with Confo Therapeutics for the discovery of therapeutic antibody candidates targeting two undisclosed GPCR targets; and strategic collaboration with Biogen Inc. to discover therapeutic antibodies for neurological conditions, as well as collaboration with Viking Global Investors and ArrowMark Partners. The company was incorporated in 2012 and is headquartered in Vancouver, Canada.

Abcellera Biologics Inc Financial Data Overview

873 M
294 M
35 787 K
Our easy-to-use no-coding solutions help you get the data effortlessly:

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'ABCL',
Type: 'Common Stock',
Name: 'Abcellera Biologics Inc',
Exchange: 'NASDAQ',
CurrencyCode: 'USD',
CurrencyName: 'US Dollar',
CurrencySymbol: '$',
CountryName: 'USA',
CountryISO: 'US',
OpenFigi: 'BBG00LLW2MF2',
ISIN: 'CA00288U1066',
CIK: '1703057',
EmployerIdNumber: NULL,
FiscalYearEnd: 'December',
IPODate: '2020-12-11',
InternationalDomestic: NULL,
Sector: 'Healthcare',
Industry: 'Biotechnology',
HomeCategory: NULL,
IsDelisted: false,

Abcellera Biologics Inc Fundamental Data is available in our Financial Data APIs

  • Net Revenue 35 787 K
  • EBITDA -203 502 000
  • Earnings Per Share -0.51
  • Income Statements
  • Balance Sheets
  • Cash flows
Get sample
of Fundamental API Data

Get Abcellera Biologics Inc Earnings via APIs

  • Latest Release 2024-05-07
  • EPS/Forecast -0.17

Get Abcellera Biologics Inc End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends
Do you have any questions?